Latest Ratios: P/E Ratio 11.3x · EV/EBITDA 10.5x · ROE 11.5%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $12.8B | $13.0B | $13.2B | $11.5B | $11.5B | $12.0B | $10.6B | $12.2B | $12.0B | $14.4B | $11.3B |
| Enterprise Value | $15.4B | $15.5B | $15.9B | $14.4B | $14.0B | $14.5B | $13.3B | $15.0B | $14.4B | $16.9B | $13.7B |
| P/E Ratio → | 11.27 | 10.18 | 13.74 | 9.55 | 16.91 | 10.00 | 15.40 | 17.71 | 14.82 | 16.08 | 13.09 |
| P/S Ratio | 0.85 | 0.88 | 0.94 | 0.88 | 0.97 | 1.04 | 0.99 | 1.13 | 1.19 | 1.51 | 1.20 |
| P/B Ratio | 1.11 | 1.12 | 1.25 | 1.16 | 1.35 | 0.94 | 0.84 | 1.00 | 1.07 | 1.18 | 0.94 |
| P/FCF | 5.86 | 5.41 | 5.33 | 5.25 | 4.70 | 6.10 | 6.07 | 6.97 | 10.67 | 12.53 | 8.86 |
| P/OCF | 5.14 | 5.22 | 5.13 | 5.04 | 4.60 | 6.02 | 5.99 | 6.88 | 9.81 | 11.51 | 7.95 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.06 | 1.14 | 1.10 | 1.18 | 1.26 | 1.25 | 1.39 | 1.42 | 1.78 | 1.46 |
| EV / EBITDA | 10.51 | 9.20 | 12.47 | 9.06 | 16.24 | 9.58 | 15.12 | 11.63 | 13.81 | 12.12 | 11.28 |
| EV / EBIT | 9.48 | 8.86 | 11.85 | 8.76 | 15.17 | 9.22 | 14.13 | 11.09 | 13.07 | 11.51 | 10.56 |
| EV / FCF | — | 6.47 | 6.43 | 6.57 | 5.73 | 7.36 | 7.60 | 8.57 | 12.77 | 14.70 | 10.78 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.7% | 30.7% | 31.9% | 33.6% | 31.5% | 32.3% | 29.1% | 33.2% | 31.8% | 31.4% | 30.4% |
| Operating Margin | 11.0% | 11.0% | 8.7% | 11.6% | 6.8% | 12.7% | 7.7% | 11.4% | 9.5% | 13.7% | 12.1% |
| Net Profit Margin | 8.7% | 8.7% | 6.9% | 9.2% | 5.7% | 10.3% | 6.5% | 9.3% | 8.0% | 9.4% | 9.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.5% | 11.5% | 9.4% | 13.1% | 6.4% | 9.3% | 5.5% | 8.5% | 6.9% | 7.4% | 7.2% |
| ROA | 2.0% | 2.0% | 1.6% | 2.1% | 1.2% | 1.9% | 1.2% | 1.8% | 1.5% | 1.7% | 1.7% |
| ROIC | 8.9% | 8.9% | 7.0% | 9.5% | 4.6% | 7.1% | 4.0% | 6.4% | 5.1% | 6.7% | 6.0% |
| ROCE | 6.1% | 6.1% | 2.0% | 2.6% | 1.4% | 2.4% | 1.4% | 2.2% | 1.8% | 2.5% | 2.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.26 | 0.26 | 0.31 | 0.33 | 0.35 | 0.24 | 0.24 | 0.25 | 0.24 | 0.23 | 0.23 |
| Debt / EBITDA | 1.76 | 1.76 | 2.51 | 2.04 | 3.47 | 2.00 | 3.53 | 2.36 | 2.57 | 2.04 | 2.23 |
| Net Debt / Equity | — | 0.22 | 0.26 | 0.29 | 0.30 | 0.19 | 0.21 | 0.23 | 0.21 | 0.20 | 0.20 |
| Net Debt / EBITDA | 1.51 | 1.51 | 2.14 | 1.82 | 2.92 | 1.64 | 3.06 | 2.17 | 2.27 | 1.79 | 2.01 |
| Debt / FCF | — | 1.06 | 1.11 | 1.32 | 1.03 | 1.26 | 1.54 | 1.60 | 2.10 | 2.17 | 1.92 |
| Interest Coverage | 13.00 | 13.00 | 10.11 | 12.95 | 8.27 | 13.94 | 7.73 | 10.34 | 7.99 | 9.14 | 8.15 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.38 | 0.38 | — | — | — | — | — | — | — | — | — |
| Quick Ratio | 0.38 | 0.38 | — | — | — | — | — | — | — | — | — |
| Cash Ratio | 0.11 | 0.11 | — | — | — | — | — | — | — | — | — |
| Asset Turnover | — | 0.21 | 0.23 | 0.22 | 0.21 | 0.19 | 0.18 | 0.19 | 0.19 | 0.18 | 0.18 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 8.1% | 8.1% | 7.8% | 6.8% | 8.5% | 5.2% | 8.9% | 7.6% | 7.4% | 5.8% | 7.2% |
| Payout Ratio | 81.9% | 81.9% | 106.9% | 65.3% | 144.0% | 52.4% | 137.7% | 92.9% | 110.2% | 93.7% | 94.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.9% | 9.8% | 7.3% | 10.5% | 5.9% | 10.0% | 6.5% | 5.6% | 6.7% | 6.2% | 7.6% |
| FCF Yield | 17.1% | 18.5% | 18.8% | 19.1% | 21.3% | 16.4% | 16.5% | 14.4% | 9.4% | 8.0% | 11.3% |
| Buyback Yield | 0.3% | 0.3% | 0.2% | 0.2% | 0.3% | 0.1% | 0.2% | 0.2% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 8.4% | 8.3% | 7.9% | 7.0% | 8.9% | 5.3% | 9.1% | 7.8% | 7.4% | 5.8% | 7.2% |
| Shares Outstanding | — | $272M | $273M | $272M | $273M | $273M | $273M | $272M | $273M | $272M | $271M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CNA stock.
CNA Financial Corporation's current P/E ratio is 11.3x. The historical average is 16.5x. This places it at the 27th percentile of its historical range.
CNA Financial Corporation's current EV/EBITDA is 10.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.7x.
CNA Financial Corporation's return on equity (ROE) is 11.5%. The historical average is 5.2%.
Based on historical data, CNA Financial Corporation is trading at a P/E of 11.3x. This is at the 27th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
CNA Financial Corporation's current dividend yield is 8.13% with a payout ratio of 81.9%.
CNA Financial Corporation has 30.7% gross margin and 11.0% operating margin. Operating margin between 10-20% is typical for established companies.
CNA Financial Corporation's Debt/EBITDA ratio is 1.8x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Catastrophe and casualty reserve adequacy
Metrics are mathematically derived from official filings.
Combined Ratio Volatility Masks Underlying Discipline
Based on reported quarterly figures, CNA's combined ratio ranged from 86.3% to 99.4% over ten quarters, with the latest 93.0% reading in 2026Q3 still below the 100% underwriting breakeven but well above the 2025Q3 low.
The swing is driven primarily by loss ratio movement, which ranged from 59.2% to 70.3%, while the expense ratio has stayed in a comparatively narrow band apart from the elevated 32.7% reading in 2026Q1. This pattern suggests underwriting results are dominated by claims and reserve timing rather than structural cost changes. Investors should monitor whether the recent drift toward 93% reflects normal catastrophe noise or the early stages of a sustained margin compression in casualty lines.
ROE Thin Relative to Peer Leaders
According to the supplied ratio series, CNA's ROE has mostly run between 2.6% and 3.7% across recent quarters, far below the 14% to 26% range reported for listed peers such as TRV, HIG, and WRB.
With the combined ratio hovering near breakeven and ROA below 0.6%, the return on equity appears to rely heavily on the investment income earned on the float rather than on underwriting profit. The gap to peers suggests either a lower-margin book or a capital base that is large relative to earnings, which would be consistent with the roughly $9.9B to $11.6B equity range. Warrants further investigation into how much of the reported return depends on net investment income versus underwriting.
Discount Reflects Thin Returns, Not Franchise Quality
As reported in the valuation metrics, CNA trades at a P/B of 1.13 and P/E of 10.26, below TRV's 2.79 P/B and HIG's 2.07, which appears to price in its lower ROE and limited public float.
A P/B near 1.1x implies the market expects returns close to the cost of equity, which is consistent with the sub-3% ROE in the ratio series. The discount may also reflect the Loews ownership structure and the limited free float, which can compress trading multiples independent of operating performance. Investors should monitor whether improving underwriting margins can close the ROE gap sufficiently to justify a re-rating toward the peer group.
Low Financial Leverage, Underwriting Capacity Unverified
Based on reported figures, CNA's debt-to-equity of 0.26 to 0.31 sits within the 0.22 to 0.29 range of most P&C peers, but premium-to-surplus data is not supplied, limiting assessment of underwriting leverage.
Financial leverage appears modest and interest coverage has stayed mostly above 9x outside the 2024Q4 trough near 1.7x, suggesting debt service is not a near-term constraint. However, true underwriting leverage depends on net premiums written relative to statutory surplus, which the data does not provide. The conclusion that the balance sheet is adequately capitalized therefore remains provisional pending statutory surplus disclosure.
Combined Ratio Overstates Underwriting Quality Without Reserve Context
The combined ratio is most commonly misapplied to CNA by treating a sub-100% reading as proof of underwriting profit, yet it omits prior-year reserve development, which is material for a casualty-heavy book.
Because CNA's Life and Group run-off and long-tail casualty exposure can generate reserve releases or strengthenings that do not appear in the current accident-year loss ratio, a benign reported combined ratio may flatter the true underlying trend. An analyst should instead examine accident-year combined ratios and reserve development tables before drawing conclusions about underwriting profitability. Absent that disclosure in the supplied data, the headline ratio should be treated as indicative rather than definitive.